文献速递胸部病理细胞病理与分子病理

液基细胞学非小细胞肺癌样本的二代测序检测

Next-generation sequencing of liquid-based cytology non-small cell lung cancer samples.
PubMed 文献 · Cancer Cytopathol · 2017-01-13

该研究验证了二代测序(NGS)技术用于液基细胞学(LBC)残留细胞沉淀检测非小细胞肺癌(NSCLC)基因突变的可行性。方法为对已知EGFR突变状态的LBC腺癌样本提取DNA,使用Ion AmpliSeq Cancer Hotspot Panel v2进行多重扩增富集和半导体测序,分析6个NSCLC相关基因的突变热点。结果显示常见EGFR序列改变(4例L858R、3例外显子19缺失、1例外显子20插入)在两种检测平台间100%一致,并发现ERBB2、KRAS、MET和PIK3CA基因突变热点中的较少见变异。结论认为NGS可成功用于LBC残留细胞沉淀的NSCLC突变分析,能同时检测多个突变热点。

要点

  • NGS可成功检测LBC残留细胞沉淀中NSCLC的基因突变。
  • 常见EGFR突变在NGS与等位基因特异性PCR间100%一致。
  • 可同时分析BRAF、EGFR、ERBB2、KRAS、MET和PIK3CA突变热点。

核心结论

  • NGS技术可用于液基细胞学残留细胞沉淀的NSCLC突变分析。

研究设计与样本

  • 回顾性验证研究,使用存档的LBC腺癌样本提取DNA,已知EGFR突变状态。
  • 采用Ion AmpliSeq Cancer Hotspot Panel v2进行多重扩增富集,OneTouch 2仪器和Ion Personal Genome Machine平台测序。
  • 使用NextGENe和Torrent Suite生物信息学工具分析6个NSCLC相关基因的突变热点。

主要发现

  • 常见EGFR序列改变包括4例L858R突变、3例外显子19缺失和1例外显子20插入,在检测平台间100%一致。
  • 在ERBB2、KRAS、MET和PIK3CA基因突变热点中也发现较少见的NSCLC变异。

临床怎么用

  • NGS可对LBC残留细胞沉淀进行多基因突变热点同时检测,有助于及时改善患者诊疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The detection of mutated epidermal growth factor receptor (EGFR) in non-small cell lung cancer (NSCLC) with residual cell pellets derived from liquid-based cytology (LBC) samples (eg, endoscopic ultrasound-guided fine-needle aspiration) has been validated with allele-specific polymerase chain reaction. The aim of this study was to validate next-generation sequencing (NGS) technology for detecting gene mutations with residual cell pellets from LBC. METHODS: Archived DNA extracted from LBC samples of adenocarcinoma stored in PreservCyt with a known EGFR mutation status was retrieved. Genomic DNA was multiplex-amplified and enriched with Ion AmpliSeq Cancer Hotspot Panel v2 chemistry and the OneTouch 2 instrument; this was followed by semiconductor sequencing on the Ion Personal Genome Machine platform. The mutation hotspots of 6 NSCLC-related genes (BRAF, EGFR, ERBB2, KRAS, MET, and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α [PIK3CA]) were analyzed with NextGENe and Torrent Suite bioinformatics tools. RESULTS: The commonly identified EGFR sequence changes, including 4 L858R mutations, 3 exon 19 deletions, and 1 exon 20 insertion, were in 100% concordance between the assay platforms. Less common NSCLC variants were also found in the mutation hotspots of ERBB2, KRAS, MET, and PIK3CA genes. CONCLUSIONS: NSCLC mutation analysis using NGS can be successfully performed on residual cell pellets derived from LBC samples. This approach allows the simultaneous examination of multiple mutation hotspots in a timely manner to improve patient care. Cancer Cytopathol 2017;125:178-187. © 2016 American Cancer Society.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Reynolds JP, Zhou Y, Jakubowski MA, et al. Next-generation sequencing of liquid-based cytology non-small cell lung cancer samples. Cancer Cytopathol. 2017. PMID: 28085233. doi:10.1002/cncy.21812

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。